Skip to main content
Skip to main content
Article · Weight Loss

How to Get a Tirzepatide Prescription Online (Step-by-Step Guide for 2026)

Getting a tirzepatide prescription no longer requires a specialist referral, a long wait at a weight loss clinic, or even leaving your home. For most people who qualify, the entire process happens onl

Evidence-Based SummaryBy the Prescriva Research Team
Apr 21, 2026 · 9 min read · Updated Apr 214 Sources
How to Get a Tirzepatide Prescription Online (Step-by-Step Guide for 2026)

Getting a tirzepatide prescription no longer requires a specialist referral, a long wait at a weight loss clinic, or even leaving your home. For most people who qualify, the entire process happens online, typically within 24 to 72 hours. This guide walks you through exactly how it works, who qualifies, what each step involves, and what to look for in a provider.

*Compounded tirzepatide is not FDA-approved. This article is for informational purposes only and does not constitute medical advice. Individual results vary. Consult a licensed healthcare provider before starting any medication.*

---

What Is Tirzepatide?

Tirzepatide is a weekly injectable medication that activates two different hormone receptors in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual action sets it apart from older GLP-1 medications like semaglutide, which activate only the GLP-1 receptor.

After you eat, both GLP-1 and GIP are released naturally. They signal fullness, slow digestion, and support blood sugar regulation. Activating both simultaneously produces greater appetite suppression than either pathway alone, which is why tirzepatide trials have shown larger average weight loss than earlier GLP-1 medications.

The branded versions, Mounjaro (approved for type 2 diabetes) and Zepbound (approved for weight management), are manufactured by Eli Lilly and have gone through the full FDA approval process. Compounded tirzepatide is prepared by licensed compounding pharmacies and is not the same product. It is not FDA-approved and has not been separately studied in equivalent clinical trials. The clinical data cited in this article comes from trials of the branded formulation.

> Important regulatory note: The FDA declared the tirzepatide shortage resolved in late 2024. As a result, the legal basis under which compounding pharmacies may prepare tirzepatide is more limited than it was during the shortage period. Under current rules, 503A compounding pharmacies may still prepare compounded tirzepatide for an individual patient when a licensed prescriber documents a specific clinical need not met by commercially available products. Prescriva works only with pharmacy partners operating in full compliance with current federal and state requirements. Ask your provider about current availability before starting treatment.

---

Who Qualifies for a Tirzepatide Prescription?

Online providers follow the same clinical criteria used in traditional medical settings. Most programs require at least one of the following:

  • A BMI of 30 or higher (the obesity classification)
  • A BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea
Beyond BMI, providers review your full health history. Tirzepatide is not appropriate for everyone. Providers screen for contraindications including:
  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • History of severe pancreatitis
  • Active pregnancy or plans to become pregnant
  • Severe gastrointestinal conditions that worsen with slowed gastric emptying
  • Prior serious allergic reactions to GLP-1 receptor agonists
If you take other glucose-lowering medications, particularly insulin, your provider will review potential interactions. You do not need to self-screen before applying. The provider reviews all of this as part of your intake.

---

Step-by-Step: How to Get a Tirzepatide Prescription Online

Step 1: Complete an Online Health Assessment

The process begins with a structured health intake form. A thorough intake covers your current weight and height, full health history, active diagnoses, current medications, prior weight loss attempts, and relevant family history.

This is not a formality. The provider uses your intake to evaluate whether tirzepatide is appropriate for you, which starting dose makes sense, and whether anything in your history requires additional attention. Most intakes take 10 to 15 minutes to complete. Complete and accurate answers matter for your safety.

Step 2: A Licensed Provider Reviews Your Case

A licensed healthcare provider, typically a clinician or nurse practitioner, reviews your intake personally. They may follow up with clarifying questions through a secure messaging system. Legitimate platforms do not use automated approvals. An actual clinical review is what separates a trustworthy program from a problematic one.

This review typically takes between a few hours and 48 hours, depending on the platform.

Step 3: Prescription Issued (If Clinically Appropriate)

If the provider determines that tirzepatide is appropriate for you, they issue a prescription. For compounded tirzepatide, this prescription is sent to a licensed compounding pharmacy. You will receive confirmation of the prescription along with your starting dose, injection schedule, and dose escalation timeline.

Starting doses are low, typically 2.5mg weekly, and increase gradually over several months to minimize side effects. Do not adjust your dose on your own. All changes should be made in coordination with your provider.

Step 4: Medication Ships Directly to You

The compounding pharmacy fills the prescription and ships the medication to your home, typically within two to five business days. Most programs include everything you need: the medication, syringes, alcohol swabs, and mixing or administration instructions.

Compounded tirzepatide medication vial with syringe on a clean surface with soft warm light, representing licensed compounding pharmacy delivery
Compounded tirzepatide medication vial with syringe on a clean surface with soft warm light, representing licensed compounding pharmacy delivery

Step 5: Ongoing Provider Monitoring

A legitimate tirzepatide program does not end at the prescription. Responsible programs include regular check-ins, support for managing side effects, dose adjustment guidance, and access to your provider through a secure portal or messaging system.

This ongoing monitoring mirrors the standard of care at a traditional clinic. Tirzepatide requires gradual dose escalation over months. Skipping or rushing this process increases the risk of side effects. A provider who stays involved throughout the process is a sign of a program worth trusting.

---

What Does Compounded Tirzepatide Cost Online?

Cost varies by provider, dose, and what is included in the program. Here is what to expect in 2026:

Compounded tirzepatide: Typically $249 to $399 per month at therapeutic doses. Most programs include provider consultation and shipping.

Brand-name Zepbound or Mounjaro: List price ranges from $900 to $1,400 per month without insurance. Most commercial insurance plans do not cover brand-name tirzepatide for weight management specifically, only for type 2 diabetes indications.

The primary reason people choose compounded tirzepatide is cost access. Brand-name pricing puts the medication out of reach for many people who qualify clinically. For a full breakdown of current pricing, see the [2026 compounded tirzepatide cost guide](/resources/compounded-tirzepatide-cost-2026).

---

Tirzepatide vs. Semaglutide: Which Should You Choose?

Both are effective GLP-1-based medications for weight management. Tirzepatide activates two receptor pathways (GLP-1 and GIP), while semaglutide activates one (GLP-1 only). Head-to-head clinical trial data from the SURMOUNT-5 trial (Aronne et al., *N Engl J Med*, May 2025; [PMID: 40353578](https://pubmed.ncbi.nlm.nih.gov/40353578)) found that participants on tirzepatide lost significantly more weight than those on semaglutide over 72 weeks (least-squares mean change −20.2% vs −13.7%).

That said, more weight loss on average does not mean tirzepatide is right for everyone. Side effect profiles are similar. Some people do better on semaglutide in terms of tolerability. Cost, availability, and your individual health history all factor in. Your provider can help you evaluate which option makes the most sense for your situation.

For a detailed comparison, see the [semaglutide vs tirzepatide guide](/resources/semaglutide-vs-tirzepatide-which-glp1-is-right-for-you).

---

What to Look For in an Online Tirzepatide Provider

Not all telehealth platforms operate to the same standard. These factors separate a safe, legitimate program from a problematic one.

Green Flags

Real clinical reviews, not automated approvals. A thorough intake followed by a personal provider review is the baseline. Any platform that approves everyone in seconds with no questions is a red flag.

Pharmacy transparency. Reputable programs tell you exactly which compounding pharmacy fills your prescription, where it is licensed, and whether it holds accreditation such as PCAB (Pharmacy Compounding Accreditation Board) certification.

Clear, all-inclusive pricing. The price you see should be the price you pay. Watch for platforms that advertise a low introductory rate and charge separately for consultations, supplies, or follow-up visits.

Ongoing monitoring built in. Dose escalation for tirzepatide spans months and requires provider oversight. A program that writes a prescription and then disappears is not providing adequate care.

Honest, compliant language. A trustworthy provider does not promise specific weight loss results, does not claim compounded tirzepatide is equivalent to Zepbound or Mounjaro, and includes appropriate disclaimers about FDA status.

Red Flags

  • Instant approval with no health intake
  • No provider contact information or unclear licensing
  • No disclosure of which pharmacy fills your prescription
  • Claims that compounded tirzepatide is FDA-approved or equivalent to Zepbound
  • No support or monitoring after the initial prescription
  • Unusually low prices with no explanation of what is included
---

How Long Does the Process Take?

From completing your intake to receiving your medication at home, most people complete the process in five to eight business days. Here is the typical breakdown:

StageTypical Timeframe
Complete health intake10 to 15 minutes
Provider review12 to 48 hours
Prescription issued (if approved)Same day as review
Pharmacy fill and ship2 to 5 business days
Medication arrives5 to 8 business days total
Some platforms offer expedited shipping. If timing matters, check shipping options before choosing a provider.

---

Is Getting a Tirzepatide Prescription Online Safe?

Yes, when the platform uses real clinical oversight and a verified, licensed compounding pharmacy. The safety considerations are the same whether you access tirzepatide through a telehealth program or a traditional clinic: accurate health history, qualified provider review, pharmacy quality standards, and ongoing monitoring throughout treatment.

The risks associated with compounded medications have more to do with pharmacy quality than with the telehealth delivery model. That is why it matters which pharmacy fills your prescription, whether the pharmacy is licensed in your state, and whether it operates under 503A or 503B oversight. A provider who cannot tell you which pharmacy they use is a provider worth avoiding.

---

Frequently Asked Questions

Can I get a tirzepatide prescription online without insurance?

Yes. Most online tirzepatide programs operate outside of insurance. Compounded tirzepatide is not covered by most insurance plans regardless of how you access it. The all-inclusive monthly pricing common to telehealth programs is designed for people paying out of pocket.

Do I need a prior diagnosis to qualify?

No prior diagnosis is required. If your BMI is 30 or higher, you may qualify on that basis alone. If your BMI is between 27 and 30, the provider will look for at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol.

Will I need lab work before starting?

Some providers require baseline labs before prescribing, others do not. If you have recent lab results available, such as a thyroid panel, metabolic panel, or lipid panel, uploading them with your intake gives the provider more clinical context to work with.

How is tirzepatide administered?

Tirzepatide is a weekly subcutaneous injection, meaning it is injected just beneath the skin, typically in the abdomen, thigh, or upper arm. The injection process takes about a minute. Most programs include detailed instructions and supplies with your first shipment.

What happens if I experience side effects?

Contact your provider. The most common side effects of tirzepatide are gastrointestinal: nausea, vomiting, constipation, or diarrhea, particularly during dose escalation. These are usually manageable with the right approach and tend to improve as your body adjusts. Your provider can recommend strategies to reduce symptoms or temporarily slow down the dose escalation schedule.

Is compounded tirzepatide the same as Zepbound?

No. Compounded tirzepatide contains tirzepatide as the active ingredient, but it is not manufactured by Eli Lilly, is not FDA-approved, and is not equivalent to the branded product. Our [compounded tirzepatide guide](/resources/compounded-tirzepatide-guide) covers the key differences in detail.

Can I switch from semaglutide to tirzepatide?

Some people do transition from semaglutide to tirzepatide, often because they have plateaued on semaglutide or want to try the dual-receptor approach. Any medication switch should happen under provider supervision with an appropriate transition period.

---

Getting Started

If you are considering tirzepatide, the first step is a health assessment. Licensed healthcare providers connected through Prescriva's platform review your intake within 24 hours. If you qualify, your medication ships within a few business days. The monthly price includes your consultation, medication, and shipping.

You can [start your assessment at Prescriva](/assessment) to find out whether you qualify.

---

Sources

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. *N Engl J Med*. 2022;387(3):205-216. [PMID: 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024)
  1. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). *N Engl J Med*. 2025;393(1):26-36. [PMID: 40353578](https://pubmed.ncbi.nlm.nih.gov/40353578)
  1. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. *Lancet*. 2023;402(10402):613-626. [PMID: 37385275](https://pubmed.ncbi.nlm.nih.gov/37385275)
  1. Tchang BG, Aras M, Kumar RB, Aronne LJ. Pharmacologic treatment of overweight and obesity in adults. In: Feingold KR, Anawalt B, Boyce A, et al., eds. *Endotext*. MDText.com, Inc.; last updated August 2024. [PMID: 25905267](https://pubmed.ncbi.nlm.nih.gov/25905267)
---

*This article is for educational purposes only. Compounded tirzepatide is not FDA-approved and is not equivalent to Zepbound or Mounjaro. This content does not constitute medical advice. Consult a licensed healthcare provider before starting any medication. Individual results vary.*

*All medical services, including prescribing, are provided by independently licensed healthcare providers. Blue Oak Services LLC dba Prescriva is a management services organization and does not practice medicine or make clinical decisions.*

*Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Prescriva is not affiliated with, endorsed by, or sponsored by Eli Lilly.*

*Regulatory information reflects the state of FDA guidance as of the publication date. Compounding regulations are subject to change. Consult with a licensed provider for current information.*

Stay informed

Weekly research updates and health guides. No spam.

References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med (2022).
  2. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med (2025).
  3. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet (2023).
  4. Tchang BG, Aras M, Kumar RB, Aronne LJ. Pharmacologic treatment of overweight and obesity in adults. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext (2024).
This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved. Always consult your healthcare provider before starting any treatment. Results may vary.

Ready to get started?

Check if you qualify for a personalized treatment plan.

Check Your Eligibility →